T-Cypher Bio
Samantha Drennan is a Principal Scientist at T-Cypher Bio with a background in cell biology and immunology. Prior to their current role, Samantha worked as a Research Fellow at the University of Birmingham and University of Southampton, focusing on post-transplant lymphoma and immunosuppression mechanisms in haematological malignancies. With a PhD in Medical Sciences from The Hull York Medical School, Samantha has a strong research background in developing innovative technologies for studying human tissue responses.
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of suchtherapies.T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.